Neuro-Oncology Reviews

Volume 28 Number 22
10 August 2026

Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 22, 10 August

Bazer D, Ayanlaja AA, Schreck KC.
Practical management of BRAF inhibitors in glioma: toxicity and resistance.
CNS Oncol. 2026 Aug 3;15(1):2711620. doi: 10.1080/20450907.2026.2711620. PMID: 42544547. ˍ

Jiang E, Dai Z, Zhao H, Zhou H, Liu M.
Multimodal cell death-associated inflammatory niches recruit but spatially constrain GZMB⁺ cytotoxic T lymphocytes in glioblastoma.
Clin Immunol. 2026 Aug 3:110757. doi: 10.1016/j.clim.2026.110757. PMID: 42546950˰ ˍ

Tiwari A, Pawlowski KD, Balyasnikova IV.
Improving T-cell engager efficacy in glioblastoma with multi-antigen targeting and novel delivery approaches.
Acta Neuropathol. 2026 Aug 3;152(1):15. doi: 10.1007/s00401-026-03063-w. PMID: 42545507. ˍ

Yan Y, Zhang B, Chen S, Sun Y, Huang J, Li G.
Rethinking glioma-associated senescence: Drivers of heterogeneity and therapeutic resistance.
Biochim Biophys Acta Rev Cancer. 2026 Aug 3;1881(5):189673. doi: 10.1016/j.bbcan.2026.189673. PMID: 42546852˰ ˍ

AlRamadneh TN, S RJ, Nayak PP, Nanda A, Hasnaawei SA, Bhatt A, Chauhan AS, Singla S, Nourizadeh M.
Microbiota-Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma.
Brain Behav. 2026 Aug 5;16(8):e71648. doi: 10.1002/brb3.71648. PMID: 42553012. ˍ

Massimino M, Stella S, Di Grazia G, Tomarchio C, Vitale SR, Martorana F, Pellegriti G, Magro G, Broggi G, Salvatorelli L, Caltabiano R, Manzella L, Vigneri P.
Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications.
Crit Rev Oncol Hematol. 2026 Aug 5:105511. doi: 10.1016/j.critrevonc.2026.105511. PMID: 42556593. ˍ

Matar H, Alrabadi B, Abu Ata A, Bahdar Z, Zagiczek M.
Depatuxizumab mafodotin in glioblastoma: A systematic review of efficacy, safety, pharmacokinetics and biomarker stratification. J Oncol Pharm Pract. 2026 Aug 5:10781552261470027. doi: 10.1177/10781552261470027. PMID: 42554799˰ ˍ

Mendonca NC, Liu L, Chen KS, Shah K.
Extracellular vesicles: Navigating new frontiers in glioblastoma therapy.
Neurotherapeutics. 2026 Aug 6;23(6):e01036. doi: 10.1016/j.neurot.2026.e01036. PMID: 42561868. ˍ

Carrion YL, Bhasin J, Anne S, Sawhney A, Ha CJ, Sharaf I, Santana J, Titkov K, Jean M, Thibault D, Pando A, Novakovic N, Parikh NS, Vojnic M, Sherman JH.
Locoregional and systemic adoptive cellular therapies for pediatric brain tumors: a systematic review of CAR-T, TCR-engineered T cells, and NK cell strategies.
Neurosurg Rev. 2026 Aug 7;49(1):519. doi: 10.1007/s10143-026-04437-0. PMID: 42566099. ˍ

Li W, Chen JM, Ma YC.
Pathway dysregulation and therapeutic resistance in glioblastoma: molecular mechanisms and emerging therapeutic targets.
Future Sci OA. 2026 Aug 10;12(1):2715646. doi: 10.1080/20565623.2026.2715646. PMID: 42573440. ˍ